No genetic association between polymorphisms in the Fyn kinase gene and age of schizophrenic onset

Neuroscience Letters

Volumn 343, Issue 1, 2003, Pages 70-72

  Ohnuma, Tohru ^a,b   Shibata, Nobuto ^a   Matsubara, Yoichiro ^a   Sato, Satoshi ^a   Yamashina, Mitsuru ^a   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Juntendo University Hospital   (Japan)

Author keywords

Fyn; Neurodevelopment; NMDA receptor; Onset; Polymorphism; Schizophrenia

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FYN GENE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

EID: 0038731214     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00310-0     Document Type: Article

References (16)

1. Bading H., Greenberg M.E. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science. 253:1991;912-914.
2. Bare D.J., Lauder J.M., Wilkie M.B., Maness P.F. p59fyn in rat brain is localized in developing axonal tracts and subpopulations of adult neurons and glia. Oncogene. 8:1993;1429-1436.
3. Cao Q., Martinez M., Zhang J., Sanders A.R., Badner J.A., Cravchik A., Markey C.J., Beshah E., Guroff J.J., Maxwell M.E., Kazuba D.M., Whiten R., Goldin L.R., Gershon E.S., Gejman P.V. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics. 43:1997;1-8.
4. Harrison P.J. Schizophrenia: a disorder of neurodevelopment? Curr. Opin. Neurobiol. 7:1997;285-289.
5. Ishiguro H., Saito T., Shibuya H., Toru M., Arinami T. Mutation and association analysis of the Fyn kinase gene with alcoholism and schizophrenia. Am. J. Med. Genet. 96:2000;716-720.
6. Kohr G., Seeburg P.H. Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J. Physiol. (Lond.). 492:1996;445-452.
7. Lafargue T., Brasic J. Neurodevelopmental hypothesis of schizophrenia: a central sensory disturbance. Med. Hypotheses. 55:2000;314-318.
8. Martinez M., Goldin L.R., Cao Q., Zhang J., Sanders A.R., Nancarrow D.J., Taylor J.M., Levinson D.F., Kirby A., Crowe R.R., Andreasen N.C., Black D.W., Silverman J.M., Lennon D.P., Nertney D.A., Brown D.M., Mowry B.J., Gershon E.S., Gejman P.V. Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. Am. J. Med. Genet. 88:1999;337-343.
9. Miyakawa T., Yagi T., Tateishi K., Niki H. Susceptibility to drug-induced seizures of Fyn tyrosine kinase-deficient mice. NeuroReport. 7:1996;2723-2726.
10. Ohnuma T., Kato H., Arai H., McKenna P.J., Emson P.C. Expression of Fyn, a non-receptor tyrosine kinase in prefrontal cortex from patients with schizophrenia and its correlation with clinical onset. Brain Res. Mol. Brain Res. 2003;. in press.
11. Saito R., Fujita N., Nagata S. Overexpression of Fyn tyrosine kinase causes abnormal development of primary sensory neurons in Xenopus laevis embryos. Dev. Growth Differ. 43:2001;229-238.
12. Shirazi S.K., Wood J.G. The protein tyrosine kinase, Fyn, in Alzheimer's disease pathology. NeuroReport. 4:1993;435-437.
13. Sperber B.R., Boyle-Walsh E.A., Engleka M.J., Gadue P., Peterson A.C., Stein P.L., Scherer S.S., McMorris F.A. A unique role for Fyn in CNS myelination. J. Neurosci. 21:2001;2039-2047.
14. Suzuki T., Okumura-Noji K. NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. Biochem. Biophys. Res. Commun. 216:1995;582-588.
15. Umemori H., Sato S., Yagi T., Aizawa S., Yamamoto T. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature. 367:1994;572-576.
16. Yagi T., Shigetani Y., Furuta Y., Nada S., Okado N., Ikawa Y., Aizawa S. Fyn expression during early neurogenesis in mouse embryos. Oncogene. 9:1994;2433-2440.